| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 77.4435 | 71 |
| GSM780708 | Untreated after 4 days (C2_1) | 98.8941 | 75 |
| GSM780709 | Untreated after 4 days (C3_1) | 96.5846 | 75 |
| GSM780719 | Untreated after 4 days (C1_2) | 85.0028 | 73 |
| GSM780720 | Untreated after 4 days (C2_2) | 110.238 | 77 |
| GSM780721 | Untreated after 4 days (C3_2) | 93.3751 | 74 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 104.195 | 76 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 88.898 | 73 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 100.09 | 75 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 90.0997 | 74 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 91.7872 | 74 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 93.9614 | 74 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 85.921 | 73 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 86.7564 | 73 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 102.767 | 76 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 86.5899 | 73 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 77.0598 | 71 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 86.4822 | 73 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 83.8737 | 72 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 81.4313 | 72 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 87.3004 | 73 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 82.6973 | 72 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 91.0693 | 74 |